1 - 25 of 86 results for author:"Stewart P." in Literature citations
Results Customize
› Repeat search in UniProtKB (116)
| Genetic predictions of prion disease susceptibility in carnivore species based on variability of the prion gene coding region. Stewart P., Campbell L., Skogtvedt S., Griffin K.A., Arnemo J.M., Tryland M., Girling S., Miller M.W., Tranulis M.A., Goldmann W. PLoS ONE 7:e50623-e50623(2012) · UniProtKB (46) |
| Common polymorphisms in the CYP11B1 and CYP11B2 genes: evidence for a digenic influence on hypertension. Alvarez-Madrazo S., Mackenzie S.M., Davies E., Fraser R., Lee W.K., Brown M., Caulfield M.J., Dominiczak A.F., Farrall M., Lathrop M. et al. Hypertension 61:232-239(2013) · Mapped (11) |
| Novel H6PDH mutations in two girls with premature adrenarche: 'apparent' and 'true' CRD can be differentiated by urinary steroid profiling. Lavery G.G., Idkowiak J., Sherlock M., Bujalska I., Ride J.P., Saqib K., Hartmann M.F., Hughes B., Wudy S.A., De Schepper J. et al. Eur. J. Endocrinol. 168:K19-K26(2013) · UniProtKB (1) |
| Cloning of the crustacean hyperglycemic hormone and evidence for molt-inhibiting hormone within the central nervous system of the blue crab Portunus pelagicus. Stewart M.J., Stewart P., Sroyraya M., Soonklang N., Cummins S.F., Hanna P.J., Duan W., Sobhon P. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 164:276-290(2013) · UniProtKB (1) |
| Coagulation factor X activates innate immunity to human species C adenovirus. Doronin K., Flatt J.W., Di Paolo N.C., Khare R., Kalyuzhniy O., Acchione M., Sumida J.P., Ohto U., Shimizu T., Akashi-Takamura S. et al. Science 338:795-798(2012) · Mapped (20) |
| Expression of 11beta-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments. Patel P., Hardy R., Sumathi V., Bartle G., Kindblom L.G., Grimer R., Bujalska I., Stewart P.M., Rabbitt E., Gittoes N.J. et al. Endocr. Relat. Cancer 19:589-598(2012) · Mapped (2) |
| Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11beta-hydroxysteroid dehydrogenase type 1. Lavery G.G., Zielinska A.E., Gathercole L.L., Hughes B., Semjonous N., Guest P., Saqib K., Sherlock M., Reynolds G., Morgan S.A. et al. Endocrinology 153:3236-3248(2012) · Mapped (6) |
| The effect of common genetic variation in 11beta-hydroxysteroid dehydrogenase type 1 on hypothalamic-pituitary-adrenal axis activity and incident depression. Dekker M.J., Tiemeier H., Luijendijk H.J., Kuningas M., Hofman A., de Jong F.H., Stewart P.M., Koper J.W., Lamberts S.W. J. Clin. Endocrinol. Metab. 97:E233-7(2012) · Mapped (1) |
| Combined SAXS/EM based models of the S. elongatus post-translational circadian oscillator and its interactions with the output His-kinase SasA. Pattanayek R., Williams D.R., Rossi G., Weigand S., Mori T., Johnson C.H., Stewart P.L., Egli M. PLoS ONE 6:e23697-e23697(2011) · Mapped (2) |
| Genotype at the P554L variant of the hexose-6 phosphate dehydrogenase gene is associated with carotid intima-medial thickness. Rahman T.J., Walker E.A., Mayosi B.M., Hall D.H., Avery P.J., Connell J.M., Watkins H., Stewart P.M., Keavney B. PLoS ONE 6:e23248-e23248(2011) · Mapped (1) |
| Can 11beta-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease? Cooper M.S., Kriel H., Sayers A., Fraser W.D., Williams A.M., Stewart P.M., Probert C.S., Tobias J.H. Calcif. Tissue Int. 89:246-251(2011) · Mapped (1) |
| Common variation at the 11-beta hydroxysteroid dehydrogenase type 1 gene is associated with left ventricular mass. Rahman T.J., Mayosi B.M., Hall D., Avery P.J., Stewart P.M., Connell J.M., Watkins H., Keavney B. Circ Cardiovasc Genet 4:156-162(2011) · Mapped (1) |
| Cortisone-reductase deficiency associated with heterozygous mutations in 11beta-hydroxysteroid dehydrogenase type 1. Lawson A.J., Walker E.A., Lavery G.G., Bujalska I.J., Hughes B., Arlt W., Stewart P.M., Ride J.P. Proc. Natl. Acad. Sci. U.S.A. 108:4111-4116(2011) · Mapped (1) |
| Biochemistry and physiology of hexose-6-phosphate knockout mice. Zielinska A.E., Walker E.A., Stewart P.M., Lavery G.G. Mol. Cell. Endocrinol. 336:213-218(2011) · Mapped (6) |
| Hexose-6-phosphate dehydrogenase contributes to skeletal muscle homeostasis independent of 11beta-hydroxysteroid dehydrogenase type 1. Semjonous N.M., Sherlock M., Jeyasuria P., Parker K.L., Walker E.A., Stewart P.M., Lavery G.G. Endocrinology 152:93-102(2011) · Mapped (12) |
| Renal PPARgamma mRNA expression increases with impairment of renal function in patients with chronic kidney disease. Lepenies J., Hewison M., Stewart P.M., Quinkler M. Nephrology (Carlton) 15:683-691(2010) · Mapped (9) |
| Cerebrospinal fluid corticosteroid levels and cortisol metabolism in patients with idiopathic intracranial hypertension: a link between 11beta-HSD1 and intracranial pressure regulation? Sinclair A.J., Walker E.A., Burdon M.A., van Beek A.P., Kema I.P., Hughes B.A., Murray P.I., Nightingale P.G., Stewart P.M., Rauz S. et al. J. Clin. Endocrinol. Metab. 95:5348-5356(2010) · Mapped (1) |
| Crystal structure of human adenovirus at 3.5 A resolution. Reddy V.S., Natchiar S.K., Stewart P.L., Nemerow G.R. |
| Localization, age- and site-dependent expression, and regulation of 11beta-hydroxysteroid dehydrogenase type 1 in skin. Tiganescu A., Walker E.A., Hardy R.S., Mayes A.E., Stewart P.M. J. Invest. Dermatol. 131:30-36(2011) · Mapped (1) |
| Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Moore L.E., Boffetta P., Karami S., Brennan P., Stewart P.S., Hung R., Zaridze D., Matveev V., Janout V., Kollarova H. et al. Cancer Res. 70:6527-6536(2010) · Mapped (9) |
| Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. Joy M.S., Boyette T., Hu Y., Wang J., La M., Hogan S.L., Stewart P.W., Falk R.J., Dooley M.A., Smith P.C. Eur. J. Clin. Pharmacol. 66:1119-1130(2010) · Mapped (31) |
| The role of 11beta-hydroxysteroid dehydrogenase 1 in adipogenesis in thyroid-associated ophthalmopathy. Tomlinson J.W., Durrani O.M., Bujalska I.J., Gathercole L.L., Tomlins P.J., Reuser T.T., Rose G.E., Curnow S.J., Stewart P.M., Walker E.A. et al. J. Clin. Endocrinol. Metab. 95:398-406(2010) · Mapped (1) |
| The hypertensiogenetic steroid 19-nor-progesterone does not influence cortisol inactivation by 11beta-hydroxysteroid dehydrogenase type 2. Lepenies J., Stewart P.M., Quinkler M. Clin. Exp. Hypertens. 31:376-379(2009) · Mapped (1) |
| 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle. Morgan S.A., Sherlock M., Gathercole L.L., Lavery G.G., Lenaghan C., Bujalska I.J., Laber D., Yu A., Convey G., Mayers R. et al. Diabetes 58:2506-2515(2009) · Mapped (7) |
| Genetic analysis of the SPRN gene in ruminants reveals polymorphisms in the alanine-rich segment of shadoo protein. Stewart P., Shen C., Zhao D., Goldmann W. J. Gen. Virol. 90:2575-2580(2009) · UniProtKB (24) |